Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Other3

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT03151876Phase 2Unknown
Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma
Lymphoma
PrincipalinvestigatorStart date: 2017-06-12
NCT03154918Phase 2Unknown
GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma
Lymphoma, Extranodal NK-T-Cell
StudydirectorStart date: 2017-06-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

West China Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03151876Phase 2PrincipalInvestigator

Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma

Lymphoma
Unknown
NCT03154918Phase 2StudyDirector

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell
Unknown
NCT03336632Phase 2StudyChair

Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT

Leukemia, AcuteMDS
Unknown

All 3 trials loaded